Brief: FDA Says CDER Proposed To Withdraw Approval Of Tavneos

Amgen

28/04/2026 01:48

April 27 (Reuters) - Amgen Inc AMGN.O:

FDA: CDER PROPOSES TO WITHDRAW APPROVAL OF TAVNEOS

FDA: NEW INFORMATION INDICATES THAT TAVNEOS HAS NOT BEEN SHOWN TO BE EFFECTIVE FOR ITS APPROVED USE

FDA: TAVNEOS WILL REMAIN ON THE MARKET UNTIL THE APPLICANT DECIDES TO REMOVE THE DRUG OR THE FDA COMMISSIONER MANDATES ITS REMOVAL

Source text: https://tinyurl.com/2abqou95

Further company coverage: AMGN.O

 ((Reuters.Briefs@thomsonreuters.com;))